BDRX - Why Is Brain Cancer Focused-Biodexa Pharmaceuticals Stock Trading Higher Today? | Benzinga
Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) shares are trading higher after the company filed an SEC Schedule 13G filing on Monday.
The filing showed that Bigger Capital Fund reported a 9.9% stake in the company with 89.11 million shares and 120.82 million warrants.
Biodexa Pharmaceuticals is a clinical-stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain.
According to data from Benzinga Pro, Biodexa Pharmaceuticals ...